1. Home
  2. GOCO vs RGNT Comparison

GOCO vs RGNT Comparison

Compare GOCO & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoHealth Inc.

GOCO

GoHealth Inc.

HOLD

Current Price

$1.14

Market Cap

17.7M

Sector

Finance

ML Signal

HOLD

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$3.00

Market Cap

20.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GOCO
RGNT
Founded
2001
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
20.4M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
GOCO
RGNT
Price
$1.14
$3.00
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$4.75
N/A
AVG Volume (30 Days)
53.5K
2.8K
Earning Date
05-14-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$361,845,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$77.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$2.73
52 Week High
$10.56
$8.35

Technical Indicators

Market Signals
Indicator
GOCO
RGNT
Relative Strength Index (RSI) 41.27 40.73
Support Level $1.00 $2.80
Resistance Level $1.35 $3.35
Average True Range (ATR) 0.10 0.18
MACD 0.02 0.04
Stochastic Oscillator 49.28 41.86

Price Performance

Historical Comparison
GOCO
RGNT

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions, so it can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. The proprietary technology platform integrates artificial intelligence and modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: